AHFS Drug Information 2025
click the link below for the full book page:
https://ebookmarket.pro/jun25/158528761X/AHFS-Drug-Information-2025
2020, 2021, 2022, 2023, 2024 Doody's Core Titles List SelectionAHFS Drug Information&1742025 contains the most dependable drug information available&8212allin one place. It is the most comprehensive evidencebased source of drug information complete with therapeutic guidelines and off-label uses.With expanded and revised content supported by more than 97,000 references and incorporating the advice of numerous subject matter experts, AHFS DI helps you protect your patients and your practice.Updates in the new edition:Clinical perspective sections that include place of therapy discussions and recommendations from therapeutic guidelinesExpanded coverage of specialty medications used to treat a variety of complex, chronic conditions that often require special handling and administration and may require careful oversight to manage severe adverse effects and dosage adjustmentsContemporary topics such as vaccines and treatments for mPox disease, new RSV treatments and vaccines, safety issues associated with the glucagon-like peptide 1 (GLP-1) agonists, novel orphan drugs, biosimilars, and moreExpanded content on new and emerging gene therapiesPharmacogenomic considerations in drug dosing and selectionUpdates to a variety of vaccine monographs including the influenza, COVID-19, pneumococcal, and RSV vaccines with the latest recommendations from the CDC Advisory Committee on Immunization Practices (ACIP)Expanded content on off-label uses, real world data and long-term clinical dataMedWatch alerts, Standardize4Safety concentration standards for IV and oral liquid medications, REMS data, and focused updates based on FDA safety findingsNew content on over 200 new molecular entities (NMEs) or new therapeutic biological products and substantive revisions on approximately 265 medicationsOncology off-label determinations based on reviews by the AHFS Oncology Expert Committee